导航阿尔茨海默病小鼠模型:与年龄相关的病理和认知缺陷
Laura Maria De Plano1, Alessandra Saitta1, Salvatore Oddo1
1Department of Chemical, Biological, Pharmaceutical and Environmental Sciences, University of Messina, Viale F. Stagno d'Alcontres 31, 98166 Messina, Italy.
Biomolecules
|November 27, 2024
概括
科学家们使用小鼠模型研究阿尔茨海默病 (AD) 的机制和治疗方法. 本综述详细介绍了常见的AD小鼠模型,为实验设计和了解疾病进展提供了指南.
科学领域:
- 神经科学是一个神经科学.
- 遗传学 是一个遗传学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 阿尔茨海默病 (AD) 研究严重依赖于动物模型.
- 鼠标模型对于理解AD病原和测试治疗方法至关重要.
研究的目的:
- 审查阿尔茨海默病的既定和新型小鼠模型.
- 为使用这些模型进行实验设计提供实用指南.
主要方法:
- 对过度表达粉样蛋白前体蛋白 (APP) 的基因工程小鼠模型的概述.
- 讨论包含tau病理的小鼠模型.
- 在APP中包含具有家族AD相关突变的模型.
主要成果:
- 自1995年以来开发的关键阿尔茨海默病小鼠模型的详细描述.
- 对不同的基因工程策略进行分析,以创建与疾病相关的表型.
结论:
- 本综述为计划AD研究的研究人员提供了宝贵的资源.
- 了解小鼠模型特征有助于有效的实验设计和解释.
相关概念视频
01:26Alzheimer's Disease: Overview
448
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
448
01:22Alzheimer's Disease: Treatment
165
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
165